EVOLUT R TRANSCATHETER AORTIC VALVE EVOLUTR-34-US

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2020-03-30 for EVOLUT R TRANSCATHETER AORTIC VALVE EVOLUTR-34-US manufactured by Medtronic Heart Valves Division.

Event Text Entries

[185601359] Other relevant device(s) are: product id: envpro-16-us, serial/lot #: (b)(4), ubd: 24-jul-2021, udi#: (b)(4). Product analysis: the valve remains implanted and the delivery catheter system (dcs) was discarded, therefore no product analysis can be performed. Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[185601360] Medtronic received information that during the implant of this transcatheter bioprosthetic valve, the patient became hemodynamically unstable following the first attempt to deploy the valve, which was partially deployed to 80%. The valve dislodged out of annular seating and was immediately recaptured. The patient? S pressures became unstable and remained that way without recovering despite advanced cardiovascular life support (acls) efforts. The valve was repositioned a second time and was fully deployed successfully, resulting in an optimal implant depth. The patient was closely monitored however the pressures remained sub-optimal. It was reported that the coronary embolization and left main coronary artery occlusion caused the patient to become hemodynamically unstable. Per the physician, the cause of the coronary occlusion was the embolization. The cause of the embolization was unknown. The patient was placed on cardiopulmonary bypass (cpb) and the procedure was converted to an open surgical procedure where the transcatheter valve was explanted. The patient died following the open surgical procedure. The cause of death was not reported. It is unknown whether an autopsy was performed.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2025587-2020-01008
MDR Report Key9900208
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2020-03-30
Date of Report2020-03-30
Date of Event2020-03-04
Date Mfgr Received2020-03-04
Device Manufacturer Date2019-08-05
Date Added to Maude2020-03-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactPAULA BIXBY
Manufacturer Street8200 CORAL SEA STREET NE
Manufacturer CityMOUNDS VIEW MN 55112
Manufacturer CountryUS
Manufacturer Postal55112
Manufacturer Phone7635055378
Manufacturer G1MEDTRONIC HEART VALVES DIVISION
Manufacturer Street1851 E DEERE AVE
Manufacturer CitySANTA ANA CA 92705
Manufacturer CountryUS
Manufacturer Postal Code92705
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEVOLUT R TRANSCATHETER AORTIC VALVE
Generic NameAORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Product CodeNPT
Date Received2020-03-30
Model NumberEVOLUTR-34-US
Catalog NumberEVOLUTR-34-US
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC HEART VALVES DIVISION
Manufacturer Address1851 E DEERE AVE SANTA ANA CA 92705 US 92705


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2020-03-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.